Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3792PDF: 1601HTML: 500Figures . Eliassian: 229 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
741PDF: 472HTML: 6273 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4334PDF: 1197HTML: 2176Figure 1: 170 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1619PDF: 809HTML: 1240Figure 1: 180Figure 2: 193Figure 3: 189 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1612PDF: 990HTML: 201 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4564PDF: 1944HTML: 17808 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1590PDF: 857HTML: 1039Picture 1: 173 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3259PDF: 1026HTML: 2033 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8051PDF: 4247HTML: 7511 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1532PDF: 1239HTML: 512 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2836PDF: 1099HTML: 122 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1317PDF: 477HTML: 18614Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA
149PDF: 82Suppl. Files: 12HTML: 2 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1730PDF: 1453HTML: 254 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4411PDF: 1726HTML: 1045 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2563PDF: 853HTML: 8902Efremov 1: 237Efremov 2: 202 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3969PDF: 1125HTML: 461 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2597PDF: 982HTML: 15118 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1611PDF: 1302HTML: 150 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1868PDF: 848HTML: 1592 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3354PDF: 588HTML: 673







